COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: First-half 2019 results - Combination at work and acceleration of the integration process - Strong free cash flow
31/07/2019
First-half 2019 results Combination at work and acceleration of the integration process Strong free cash flow 7 Revenue growth of 7.3% 1 (+3.9% 1 at constant exchange rates 2 ) 2Q sales growth higher than in 1Q at [...]
EssilorLuxottica : Résultats du 1er semestre 2019 - Le rapprochement se poursuit et le processus d’intégration s’accélère - Forte génération de cash-flow libre
31/07/2019
Résultats du 1 er semestre 2019 Le rapprochement se poursuit et le processus d’intégration s’accélère Forte génération de cash-flow libre 7 Croissance du chiffre d’affaires de 7,3 % 1 , dont 3,9 % 1 à taux de change [...]
U.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer (nmCRPC)
31/07/2019
ORION CORPORATION PRESS RELEASE 31 JULY 2019 at 7.30 EEST U.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer (nmCRPC) Approval of darolutamide is based on [...]
MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in Japan
31/07/2019
LA JOLLA, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Ascent Industries Provides Update on the Supreme Court of British Columbia in the Matter of the Companies Creditor Arrangement Act
30/07/2019
VANCOUVER, British Columbia, July 30, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ” or the “ Company ”) is providing an update on the Supreme Court of British Columbia hearing, in the matter [...]
Emergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile
30/07/2019
AV7909 next generation vaccine positioned as primary solution for U.S. government’s anthrax preparedness and response efforts GAITHERSBURG, Md., July 30, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) [...]
PLx Pharma Inc. to Discuss 2019 Second Quarter Financial Results on August 9, 2019 Conference Call
30/07/2019
HOUSTON, July 30, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Opiant Pharmaceuticals to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on Thursday, August 8
30/07/2019
SANTA MONICA, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced [...]
Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019
30/07/2019
BURLINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2019 financial results after the close of the U.S. financial markets [...]
Profound Medical to Release Second Quarter 2019 Financial Results on August 14 – Conference Call to Follow
30/07/2019
TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019
30/07/2019
CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
Amedisys to Acquire Home Health Regulatory Assets Expanding Access in New York
30/07/2019
BATON ROUGE, La., July 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire regulatory [...]
EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
30/07/2019
WATERTOWN, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
The Cooper Companies Announces Release Date for Third Quarter 2019
30/07/2019
PLEASANTON, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release third quarter 2019 financial results on Thursday, August 29, 2019, at 4:15 PM ET. Following [...]
Dova Pharmaceuticals to Announce Second Quarter 2019 Financial Results on August 6, 2019
30/07/2019
DURHAM, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Tuesday, August 6, 2019 at 9:00 a.m. ET to discuss second quarter 2019 financial results and [...]
InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6
30/07/2019
Management to host conference call and webcast at 8am ET TEL AVIV, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the [...]
Prothena to Report Second Quarter 2019 Financial Results on August 6
30/07/2019
DUBLIN, Ireland, July 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2019 on [...]
ORYZON Reports Financial Results and Corporate Update for the First Half Ended June 30, 2019
30/07/2019
MADRID, Spain and CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies [...]
BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results
30/07/2019
Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of [...]

Pages